MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Serum uric acid level as a biomarker in sporadic and familial (p.A53T alpha synuclein carriers) Parkinson’s disease: Longitudinal data from the PPMI study

    C. Koros, AM. Simitsi, M. Stamelou, D. Papadimitriou, A. Bougea, I. Pachi, N. Papagiannakis, A. Prentakis, E. Angelopoulou, R. Antonellou, M. Bozi, X. Geronicola Trapali, L. Stefanis (Athens, Greece)

    Objective: To determine whether there are longitudinal differences in serum uric acid level among sporadic Parkinson’s disease (PD) patients, PD patients harboring the p.A53T mutation…
  • 2019 International Congress

    Patients Experiencing Motor Fluctuations With Parkinson’s Disease (PD): Participant Characteristics in the Accordance Phase 3 Efficacy and Safety Trial of Accordion Pill™ Carbidopa/Levodopa

    P. Lewitt, R. Gendreau, J. Meckler, A. Hotovely-Salomon, N. Navon (West Bloomfield, MI, USA)

    Objective: To provide baseline and clinical characteristics for participants in the phase 3 Accordance study of the Accordion Pill™ (AP)—a gastric-retentive formulation of carbidopa/levodopa (CD/LD)—versus…
  • 2019 International Congress

    Repetitive transcranial magnetic stimulation can improve anxiety in Parkinson’s disease: a randomized, double-blind and controlled trial

    A. Makkos-Weisz, N. Kovács, P. Endre, M. Kovács, D. Pintér (Pécs, Hungary)

    Objective: High frequrncy (HF) repetitive transcranial magnetic stimulation (rTMS) improve anxiety in Parkinson’s Disease (PD). Background: The high frequency repetitive transcranial magnetic stimulation above the…
  • 2019 International Congress

    Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s Disease

    R. Moraes, J. Freitas, R. Ferreira, P. Pereira, P. Terzian, F. Godinho, M. Rocha (Sao Paulo, Brazil)

    Objective: To evaluate patient-centered outcomes after deep brain stimulation in Parkinson's disease. Background: Deep brain stimulation (DBS) is an effective treatment for Parkinson's disease (PD) patients. Long-term…
  • 2019 International Congress

    Parkinsonian syndrome associated to C9orf72 expansion

    S. Novo Ponte, E. Gamo González, P. Sánchez Alonso (Majadahonda, Spain)

    Objective: To describe a case of parkinsonian syndrome associated to C9Orf72 expansion followed by ALS development Background: C9Orf72 expansions are known to be the most…
  • 2019 International Congress

    Detection of impaired finger dexterity by objective keyboard typing test in Parkinson’s Disease: A feasibility study

    P. Panyakaew, K. Duangjino, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To objectively evaluate finger dexterity in Parkinson’s disease (PD) patients by keyboard typing test. Background: Impaired motor dexterity is a type of bradykinesia which…
  • 2019 International Congress

    Impulse control disorders and (romantic) jealousy in Parkinson’s disease: a patients’ vs. partners’ perspective

    E. Pipan, S. Delalić, A. Herzog, M. Trošt, Z. Pirtošek, D. Flisar, N. Kovacs, D. Georgiev (Ljubljana, Slovenia)

    Objective: To compare self-reported symptoms of (romantic) jealousy and impulse control disorders (ICD) in Parkinson’s disease (PD) patients to those reported by their partners. Background:…
  • 2019 International Congress

    Does automated analysis of repeat DaTscan imaging aid diagnosis in suspected Lewy body disorders?

    F. Richardson, N. Vennart, P. Bartholomew, C. Mcdonald (Gateshead, United Kingdom)

    Objective: To establish if repeat SPECT imaging, using automated quantitative analysis, aids diagnosis in suspected Lewy Body Disorders (LBD). Background: Patients with suspected LBD are…
  • 2019 International Congress

    An atypical and interesting feature of Parkinson´s disease

    B. Santos, M. Spitz (Rio de Janeiro, Brazil)

    Objective: To describe the symptoms of three PD patients who exhibited marked facial asymmetry. We also briefly review the literature regarding hemihypomimia in PD and…
  • 2019 International Congress

    Clinical and imaging characteristics of non-manifest LRRK2 and GBA carriers: The PPMI cohort

    A. Siderowf, T. Simuni, L. Uribe, C. Caspell-Garcia, H. Cho, C. Coffey, T. Foroud, B. Mollehauer, C. Tanner, K. Kieburtz, L. Chahine, D. Weintraub, K. Marek (Philadelphia, PA, USA)

    Objective: To examine baseline clinical and dopamine transporter (DAT) imaging characteristics in a cohort of non-manifest carriers (NMC) of GBA and LRRK2 compared to healthy…
  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley